MarketPeel
Insider Trading Intelligence
SS

Stephen L. Sabba

LGND
DIRECTOR · LIGAND PHARMACEUTICALS INC · CIK 0001442372
FILING MIX · LIFETIME54%/46%
BUYS
19
SELLS
16
TOTAL VALUE
$5.43M
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
35,774
AVG SELL PX
$172.52
TRADE KIND
SHOWING 35 / 35
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 6 pending
Forward-return performance of every backtestable P/S trade by Stephen L. Sabba, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+66.67%-8.53%-0.09%-8.44%-2.19%
14d6+66.67%-11.76%-0.12%-11.64%-3.93%
30d6+66.67%-7.23%+2.03%-9.26%-3.87%
60d6+66.67%-7.61%+5.10%-16.42%-16.86%
90d6+50.00%-4.42%+8.46%-16.49%-22.58%
180d6(2 pending)+75.00%-21.64%+11.56%-33.20%-50.41%
1y6(2 pending)+50.00%-4.27%+20.47%-24.74%-38.83%
2y6(2 pending)+50.00%+19.55%+22.94%-3.40%-40.41%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LGND · 35,774 shares · as of Jun 16, 2026
09,77519,55129,32639,101202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 19 buys / 16 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,1450Jun 16, 2026Jun 18, 2026View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,145$254.00$544.8K33,629Jun 16, 2026Jun 18, 2026View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
2,145$66.13$141.8K35,774Jun 16, 2026Jun 18, 2026View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
83633,629Jun 5, 2026Jun 9, 2026View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,9382,938Jun 5, 2026Jun 9, 2026View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
1,000$207.87$207.9K32,793Mar 23, 2026Mar 25, 2026View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,034$201.50$409.9K33,793Mar 3, 2026Mar 5, 2026View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,0340Mar 3, 2026Mar 5, 2026View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
2,034$69.51$141.4K35,827Mar 3, 2026Mar 5, 2026View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,20933,793Jun 6, 2025Jun 10, 2025View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,7835,783Jun 6, 2025Jun 10, 2025View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
2,406$52.30$125.8K32,584Apr 1, 2025Apr 16, 2025View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,4060Apr 1, 2025Apr 16, 2025View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,4445,444Jun 14, 2024Jun 25, 2024View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,25230,178Jun 14, 2024Jun 25, 2024View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
2,89330,819Mar 5, 2024Mar 7, 2024View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
2,893419Mar 5, 2024Mar 7, 2024View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
1,893$74.30$140.6K28,926Mar 5, 2024Mar 7, 2024View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,14226,926Jun 9, 2023Jun 21, 2023View →
LGND
LIGAND PHARMACEUTICALS INC
SALEGRANT
Stock grant
5,4615,461Jun 9, 2023Jun 21, 2023View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
6,408$77.13$494.2K25,784May 10, 2023May 12, 2023View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
6,40832,192May 10, 2023May 12, 2023View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
6,408927May 10, 2023May 12, 2023View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
6,6236,623Dec 22, 2022Dec 27, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,00426,065Jun 10, 2022Jun 14, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
SALEGRANT
Stock grant
4,3404,340Jun 10, 2022Jun 14, 2022View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
63025,061Jun 4, 2021Jun 8, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALEGRANT
Stock grant
3,2693,269Jun 4, 2021Jun 8, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
7,3350Feb 9, 2021Feb 11, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
556$208.00$115.6K38,545Feb 9, 2021Feb 11, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
SALE
14,114$208.55$2.94M24,431Feb 9, 2021Feb 11, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
7,335$12.53$91.9K39,101Feb 9, 2021Feb 11, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASE
7,335$10.12$74.2K31,766Feb 9, 2021Feb 11, 2021View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
2,4682,468Jun 10, 2020Jun 12, 2020View →
LGND
LIGAND PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
83124,431Jun 10, 2020Jun 12, 2020View →
Other insiders · LGND
Loading peer insiders…
About this filer
CIK 0001442372
ROLE
Director
PRIMARY
LGND
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001442372DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback